-+ 0.00%
-+ 0.00%
-+ 0.00%

Truist Securities Initiates Coverage On Abivax with Buy Rating, Announces Price Target of $140

Benzinga·11/24/2025 17:47:30
Listen to the news
Truist Securities analyst Gregory Renza initiates coverage on Abivax (NASDAQ:ABVX) with a Buy rating and announces Price Target of $140.